Virologic and genetic evaluation of vemurafenib-induced skin cancers

Emi Dika1, Annalisa Patrizi, Annalisa Altimari

  • 1Dermatology, Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna , Bologna , Italy .

Insights

Vemurafenib therapy for advanced melanoma can cause giant squamous cell carcinoma (SCC). In one case, SCC regressed after discontinuing vemurafenib, suggesting a link between the drug and tumor development.

Area of Science:

  • Oncology
  • Dermatology
  • Pharmacology

Background:

  • Vemurafenib is a targeted therapy used for advanced melanoma.
  • Cutaneous side effects, including squamous cell carcinoma (SCC) and keratoacanthomas, are known complications of vemurafenib treatment.

Observation:

  • A patient undergoing vemurafenib therapy for metastatic melanoma developed a giant squamous cell carcinoma.
  • This specific case involved a large SCC, a known but less common side effect of vemurafenib.

Findings:

  • While SCCs associated with vemurafenib are typically managed surgically, this giant SCC showed complete regression upon cessation of the drug.
  • This observation supports a direct causal relationship between vemurafenib and the development of SCC in some patients.

Implications:

  • Discontinuation of vemurafenib may be a viable treatment strategy for drug-induced SCC, potentially avoiding surgical intervention.
  • Further research is warranted to understand the mechanisms underlying vemurafenib-induced SCC and to optimize management strategies for melanoma patients experiencing these side effects.

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
5.2K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

4.8K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
5.2K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.7K